About

Our editorial approach

Separate the questions before answering them.

Near Beacon 42 is built for readers who need a calm way to orient themselves around a complex subject. The Australian access overview is structured to keep distinct processes distinct, rather than presenting one label as if it resolves every practical question.

We work from official registers, regulator material, research records, and published literature where those sources are relevant. For example, the Therapeutic Goods Administration is a primary point of reference for Australian therapeutic goods information, while trial records can be checked against the Australian New Zealand Clinical Trials Registry.

Clarity is not certainty. Where a source is limited, dated, or open to interpretation, we say so.

Who this is for

For readers looking for a better starting point.

This resource is intended for Australians seeking cautious background information and a way to frame questions. It can also help readers place material encountered elsewhere into context, whether they are comparing ibogaine treatment facilities, looking at ibogaine information in the United States, or trying to understand Canadian treatment cost discussions.

International material can be useful for identifying terminology, but it is not a substitute for local source checking. That distinction also applies to accounts of treatment in Mexico and descriptions of Oregon-based access discussions.